Overview
Chandra Prasad practices in New Delhi, India. Ms. Prasad is rated as an Experienced expert by MediFind in the treatment of Hydatidiform Mole. Her top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Gallbladder Cancer, and Gallbladder Disease.
Her clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hydatidiform Mole.
Locations
New Delhi, DL, India
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Triple-Negative Breast CancerMs. Prasad isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Breast CancerMs. Prasad isAdvanced. Learn about Breast Cancer.
- Gallbladder CancerMs. Prasad isAdvanced. Learn about Gallbladder Cancer.
- Gallbladder DiseaseMs. Prasad isAdvanced. Learn about Gallbladder Disease.
- Experienced
- Bladder CancerMs. Prasad isExperienced. Learn about Bladder Cancer.
- Gestational Trophoblastic DiseaseMs. Prasad isExperienced. Learn about Gestational Trophoblastic Disease.
- HER-2 Positive Breast CancerMs. Prasad isExperienced. Learn about HER-2 Positive Breast Cancer.
- Hydatidiform MoleMs. Prasad isExperienced. Learn about Hydatidiform Mole.
- MelanomaMs. Prasad isExperienced. Learn about Melanoma.
- Multiple MyelomaMs. Prasad isExperienced. Learn about Multiple Myeloma.